Skip to content
DataLookout
Menu

SHARESNCT04549571

Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 23 versions: 21 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Results posted: Oct 27, 2026
    • Trial completed
    • Enrollment increased: 543 → 614 participants
    • Study completion date changed from estimate of Jan 2027 to Jul 12, 2024
  2. Notable Results first posted: Oct 27, 2026 Show 7 more changesShow less
    • Eligibility criteria expanded, about 15 words
    • Enrollment target: 543 to 614
    • Secondary endpoints revised (2)
    • Primary endpoint revised
    • Study description revised
    • Site details revised at 3 of 27 sites
    • Publications: 1 to 2
  3. Minor Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 700 to confirmed 543
    • Primary completion date changed from estimate of Jan 2025 to May 1, 2024
    • Study sites revised (27)
    v21
  4. Minor Site details revised at 4 of 27 sitesv20
  5. Minor Study sites revised (27)v19
Show 15 earlier versionsHide 15 earlier versions
  1. Notable Start date: Jan 15, 2021 to Feb 16, 2021
    • Site contacts updated at 1 of 27 sites
    v18
  2. Notable Primary completion date: Jan 2024 to Jan 2025v17
  3. Minor Site details revised at 13 of 27 sitesv16
  4. Minor Primary completion date: Nov 2023 to Jan 2024v15
  5. Minor Site details revised at 3 of 27 sitesv14
  6. Minor Site details revised at 6 of 27 sitesv13
  7. Minor Site details revised at 13 of 27 sitesv12
  8. Notable Primary completion date: Nov 2022 to Nov 2023
    • Study completion date: Jan 2026 to Jan 2027
    v11
  9. Minor Site contacts updated at 1 of 27 sitesv10
  10. Minor Study sites: 25 to 27v8
  11. Minor Study sites: 23 to 25v6
  12. Minor Study sites: 22 to 23v5
  13. Minor Study sites: 16 to 22v4
  14. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 16
    • Start date changed from estimate of Jan 2021 to Jan 15, 2021
    v3
  15. Minor Secondary endpoints revised (2)v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Patient Knowledge About Risks and Benefits of Local Regional Treatment
Timeframe: 5 weeks

Secondary (2)

Patient Self-efficacy in Dealing With Breast Cancer
Patient Cancer Worry

Arms and interventions

Arm I: (iCanDecide - ESE)Experimental

Patients utilize the iCanDecide - ESE website, then undergo surgery within 5 weeks of registration. Patients may also participate in an audio-recorded phone interview over 20 minutes at 9-12 months post registration.

Arm II: (iCanDecide - S)Active comparator

Patients utilize the iCanDecide - S website, then undergo surgery within 5 weeks of registration. Patients may also participate in an audio-recorded phone interview over 20 minutes at 9-12 months post registration.

Clinics 1-5: (CDB)Experimental

Beginning 4 weeks before the practice begins use of the CDB, clinicians receive training on how to use the CDB and utilize the CDB over weeks 1-60. Clinicians may also participate in an audio-recorded phone interview over 20 minutes.

Clinics 6-8 (CDB)Experimental

Beginning 4 weeks before the practice begins use of the CDB, clinicians receive training on how to use the CDB and utilize the CDB over weeks 10-60. Clinicians may also participate in an audio-recorded phone interview over 20 minutes.

Clinics 9-11 (CDB)Experimental

Beginning 4 weeks before the practice begins use of the CDB, clinicians receive training on how to use the CDB and utilize the CDB over weeks 20-60. Clinicians may also participate in an audio-recorded phone interview over 20 minutes.

Clinics 12-14 (CDB)Experimental

Beginning 4 weeks before the practice begins use of the CDB, clinicians receive training on how to use the CDB and utilize the CDB over weeks 30-60. Clinicians may also participate in an audio-recorded phone interview over 20 minutes.

Clinics 15-17 (CDB)Experimental

Beginning 4 weeks before the practice begins use of the CDB, clinicians receive training on how to use the CDB and utilize the CDB over weeks 40-60. Clinicians may also participate in an audio-recorded phone interview over 20 minutes.

Clinics 18-20 (CDB)Experimental

Beginning 4 weeks before the practice begins use of the CDB, clinicians receive training on how to use the CDB and utilize the CDB over weeks 50-60. Clinicians may also participate in an audio-recorded phone interview over 20 minutes.

Clinics 21-25 (usual care)Active comparator

Beginning 4 weeks before the practice begins use of the CDB, clinicians receive training on how to use the CDB and continue to provide breast cancer surgical care per their usual care. Clinicians may also participate in an audio-recorded phone interview over 20 minutes.

Other: Decision Aid iCanDecide - ESE website, Decision Aid iCanDecide - S website, Interview, Training, Media Intervention, Best Practice, Survey Administration, Quality-of-Life Assessment

Procedures: Therapeutic Conventional Surgery

Sites

27 sites in 1 country